Skip to content
Use caution Medical device recall · FDA · Published March 4, 2025

Medtronic Neuromodulation Stimulation RC Clinician Programmer Model A71400 Recall

Medtronic Neuromodulation recalls Stimulation RC Clinician Programmer Application Model A71400 when used with specific neurostimulators due to a software issue that can permanently disable communication with implantable neurostimulators during certain programming sequences.

🇺🇸 FDA recall #Z-1543-2025Medical deviceMedtronic Neuromodulation ›
Take action

Contact the company

Recalling firmMedtronic Neuromodulation7000 Central Ave Ne · Minneapolis, MN 55432-3568
✎ GovInfoNow plain-language explainer

What happened, in plain English

Medtronic Neuromodulation is recalling its Stimulation RC Clinician Programmer Application Model A71400 when used with Inceptiv (Model 977119) and Intellis Pro (Model 977118) neurostimulators. This software issue can permanently disable communication with an implantable neurostimulator during specific intraoperative programming sequences, potentially causing treatment to stop working. Read more at govinfonow.com/recall/52683-medtronic-neuromodulation-stimulation-rc-clinician-programmer-model-a71400-recall-software.

Source Summary by GovInfoNow · govinfonow.com/recall/52683-medtronic-neuromodulation-stimulation-rc-clinician-programmer-model-a71400-recall-software · Updated August 18, 2026 · FDA enforcement record: FDA #Z-1543-2025

Cite this page

“Medtronic Neuromodulation Stimulation RC Clinician Programmer Model A71400 Recall.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/52683-medtronic-neuromodulation-stimulation-rc-clinician-programmer-model-a71400-recall-software. Based on FDA recall #Z-1543-2025 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1543-2025%22&limit=1).

Why it’s dangerous

The software issue can permanently disable communication with an implantable neurostimulator (INS) when a specific intraoperative programming sequence is used. This means the device may stop working during surgery, potentially causing treatment to stop working without warning.

Who’s affected

Patients using Medtronic's implantable neurostimulators with the recalled Stimulation RC Clinician Programmer Application Model A71400 are most at risk. Healthcare professionals who program these devices during surgery are also affected.

How to tell if you have this one

Check for the Stimulation RC Clinician Programmer Application Model A71400. It is used with Inceptiv (Model 977119) and Intellis Pro (Model 977118) neurostimulators. The recall includes specific serial numbers listed in the UDI-DI: 00763000371463.

  • Brand
    Medtronic Neuromodulation
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Device Compatibility

    Verify if your Stimulation RC Clinician Programmer Application Model A71400 is used with Inceptiv (Model 977119) or Intellis Pro (Model 977118) neurostimulators.

  2. Contact Manufacturer

    Reach out to Medtronic Neuromodulation for guidance on next steps if your device is affected.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Worldwide Distribution: US (Nationwide) and OUS (Global) to countries of: Austria, Belgium, Bulgaria, Canary Islands, Cyprus, Croatia, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Japan,…” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA published this recall 43 days after the firm started it.

1. Firm started the recall: Mar 4, 202512. FDA classified it Class II: Apr 8, 202523. Published in FDA’s Enforcement Report: Apr 16, 202532025
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1543-2025 (March 4, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1543-2025 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA